Catalyst Pharmaceuticals has a total of 17 patents globally, out of which 9 have been granted. Of these 17 patents, 70.58% patents are active. United States of America is where Catalyst Pharmaceuticals has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Catalyst Pharmaceuticals.
Founded in 2002, Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing, acquiring, licensing, and commercializing therapies for rare and difficult-to-treat neuromuscular and neurological disorders. Headquartered in Coral Gables, Florida, the company leverages its expertise in rare disease commercialization, patient support, and strategic partnerships to expand access to innovative treatments. Catalyst is committed to addressing unmet medical needs and improving outcomes for patients with rare diseases.
In July 2026, Angelini Pharma completed its acquisition of Catalyst Pharmaceuticals, expanding its global presence in Brain Health and Rare Diseases while establishing a stronger foothold in the U.S. market. The acquisition combines Catalyst’s commercial portfolio, rare disease expertise, and U.S. infrastructure with Angelini Pharma’s global capabilities, creating a stronger platform for delivering innovative therapies. This milestone reinforces the company’s commitment to expanding access to life-changing treatments and improving patient outcomes worldwide.
Do read about some of the most notable patents of Catalyst Pharmaceuticals covered in this article. You can also explore Catalyst Pharmaceuticals’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Catalyst Pharmaceuticals have?
Catalyst Pharmaceuticals has a total of 17 patents globally. These patents belong to 8 unique patent families. Out of 17 patents, 12 patents are active.
How Many Patents did Catalyst Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Catalyst Pharmaceuticals Applications Filed | Catalyst Pharmaceuticals Patents Granted |
| 2025 | 2 | 1 |
| 2022 | 4 | – |
| 2020 | 3 | 1 |
| 2017 | 1 | 1 |
| 2016 | 1 | – |
| 2015 | – | 1 |
| 2014 | 1 | 1 |
| 2012 | – | 1 |
| 2010 | 1 | 2 |
| 2007 | 2 | – |
How many Catalyst Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Catalyst Pharmaceuticals File in Different Countries?
Countries in which Catalyst Pharmaceuticals Filed Patents
| Country | Patent |
| United States of America | 10 |
| Japan | 3 |
| Europe (EPO) | 1 |
Track Every Patent Move in Real Time Across 70+ Jurisdictions with Elixir
Where are Research Centres of Catalyst Pharmaceuticals Patents Located?
Best Catalyst Pharmaceuticals Patents
WO2017051180A1 is the most popular patent in the Catalyst Pharmaceuticals portfolio. It has received 34 citations so far from companies like Companies, Honeywell International Inc and Proveris Scientific Corporation.
Below is the list of most cited patents of Catalyst Pharmaceuticals:
| Publication Number | Citation Count |
| WO2017051180A1 | 34 |
| US10724928B2 | 3 |
| WO2021093975A1 | 2 |
| WO2023139381A1 | 1 |
| CN108027303B | 1 |
What Percentage of Catalyst Pharmaceuticals US Patent Applications Were Granted?
Catalyst Pharmaceuticals (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 100%
Below are the key stats of Catalyst Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Catalyst Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Sterne Kessler Goldstein & Fox PLLC | 9 | 100.0% |
| Covington & Burling Llp | 1 | 100.0% |
What are Catalyst Pharmaceuticals key innovation segments?
What Technologies are Covered by Catalyst Pharmaceuticals?
The chart below distributes patents filed by Catalyst Pharmaceuticals